Global Markets
US FDA has withdrawn the approval of the NDA for Wellcovorin, at the request of GSK (GSK LN)
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
